ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,075 | -26.8% | 14,020 | -3.7% | 0.04% | -26.7% |
| Q1 2023 | $128,502 | +17.7% | 14,553 | +1.9% | 0.06% | +42.9% |
| Q4 2022 | $109,136 | +47.5% | 14,285 | +37.1% | 0.04% | 0.0% |
| Q3 2022 | $74,000 | -14.0% | 10,422 | -2.5% | 0.04% | -12.5% |
| Q2 2022 | $86,000 | -45.2% | 10,693 | -5.8% | 0.05% | +2.1% |
| Q1 2022 | $157,000 | -29.0% | 11,355 | +204.1% | 0.05% | +20.5% |
| Q4 2020 | $221,000 | – | 3,734 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |